BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34853141)

  • 1. Metastatic 4S neuroblastoma with excellent outcome in Saudi cancer center.
    AlZhrani WA; Elimam NA; Almehdar AS; Bassem SM; Abdullatif DE; Ahmed KD; Baothman AA
    Saudi Med J; 2021 Dec; 42(12):1353-1356. PubMed ID: 34853141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage 4S neuroblastoma, a disseminated tumor with excellent outcome.
    Elimam NA; Atra AA; Fayea NY; Al-Asaad TG; Khattab TM; Al-Sulami GA; Felimban SK
    Saudi Med J; 2006 Nov; 27(11):1734-6. PubMed ID: 17106552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroblastoma 4S: a heterogeneous disease with variable risk factors and treatment strategies.
    van Noesel MM; Hählen K; Hakvoort-Cammel FG; Egeler RM
    Cancer; 1997 Sep; 80(5):834-43. PubMed ID: 9307181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinico-pathological patterns of a rare presentation of abdominal neuroblastoma in children.
    Aldaqal SM; Turki AM
    Afr J Paediatr Surg; 2013; 10(2):100-7. PubMed ID: 23860056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
    Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
    J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study.
    Nickerson HJ; Matthay KK; Seeger RC; Brodeur GM; Shimada H; Perez C; Atkinson JB; Selch M; Gerbing RB; Stram DO; Lukens J
    J Clin Oncol; 2000 Feb; 18(3):477-86. PubMed ID: 10653863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age.
    Taggart DR; London WB; Schmidt ML; DuBois SG; Monclair TF; Nakagawara A; De Bernardi B; Ambros PF; Pearson AD; Cohn SL; Matthay KK
    J Clin Oncol; 2011 Nov; 29(33):4358-64. PubMed ID: 21969516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531.
    Twist CJ; Naranjo A; Schmidt ML; Tenney SC; Cohn SL; Meany HJ; Mattei P; Adkins ES; Shimada H; London WB; Park JR; Matthay KK; Maris JM
    J Clin Oncol; 2019 Jan; 37(2):115-124. PubMed ID: 30444686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management and Outcomes of Children with Stage 4S (MS) Neuroblastoma: A Single-Center Experience from a Resource-Challenged Nation.
    Anand S; Agarwala S; Jain V; Dhua A; Bakhshi S; Jana M; Kandasamy D; Biswas A
    Indian J Pediatr; 2023 Mar; 90(3):220-226. PubMed ID: 36112265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the prognosis of stage 4s neuroblastoma in patients 12 months of age and older really excellent?
    Iehara T; Hiyama E; Tajiri T; Yoneda A; Hamazaki M; Fukuzawa M; Hosoi H; Sugimoto T; Sawada T
    Eur J Cancer; 2012 Jul; 48(11):1707-12. PubMed ID: 22305511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factor analysis of stage 4S neuroblastoma in infant patients: A single center study.
    Wang Z; Sun H; Li K; Yao W; Dong K; Ma Y; Zheng S
    J Pediatr Surg; 2019 Dec; 54(12):2585-2588. PubMed ID: 31521373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641.
    Strother DR; London WB; Schmidt ML; Brodeur GM; Shimada H; Thorner P; Collins MH; Tagge E; Adkins S; Reynolds CP; Murray K; Lavey RS; Matthay KK; Castleberry R; Maris JM; Cohn SL
    J Clin Oncol; 2012 May; 30(15):1842-8. PubMed ID: 22529259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of bone marrow evaluation in the staging of patients with otherwise localized, low-risk neuroblastoma.
    Russell HV; Golding LA; Suell MN; Nuchtern JG; Strother DR
    Pediatr Blood Cancer; 2005 Dec; 45(7):916-9. PubMed ID: 16078212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral adrenal primary tumor in Stage 4S neuroblastoma: The Italian experience and review of the literature.
    Montalto S; Sertorio F; Podda M; Sorrentino S; Di Cataldo A; Provenzi M; Nonnis A; D'Ippolito C; Corrias MV; De Bernardi B
    Pediatr Hematol Oncol; 2022 Aug; 39(5):441-452. PubMed ID: 35139733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term follow-up of neuroblastoma in children less than 18 months of age].
    Zhao J; Pan C; Xu M; Zhou M; Gao YJ; Hu WT; Tang JY
    Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):754-759. PubMed ID: 29050113
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroblastoma in Turkish children: experience of a single center.
    Aydn GB; Kutluk MT; Yalçn B; Büyükpamukçu M; Kale G; Varan A; Akyüz C; Senocak ME; Büyükpamukçu N
    J Pediatr Hematol Oncol; 2009 Jul; 31(7):471-80. PubMed ID: 19564739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [4S neuroblastoma with bilateral adrenal tumors].
    Kerdudo C; Corradini N; Michon J; Leverger G
    Arch Pediatr; 2004 Dec; 11(12):1450-6. PubMed ID: 15596333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locoregional control in infants with neuroblastoma: role of radiation therapy and late toxicity.
    Paulino AC; Mayr NA; Simon JH; Buatti JM
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1025-31. PubMed ID: 11958898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic progression in infants diagnosed with stage 4S neuroblastoma. A study of the Italian Neuroblastoma Registry.
    Parodi S; Sorrentino S; Cataldo AD; Tondo A; Fagnani AM; Perri P; Gigliotti AR; Erminio G; Corrias MV; De Bernardi B
    Pediatr Blood Cancer; 2021 May; 68(5):e28904. PubMed ID: 33459514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group study.
    Nuchtern JG; London WB; Barnewolt CE; Naranjo A; McGrady PW; Geiger JD; Diller L; Schmidt ML; Maris JM; Cohn SL; Shamberger RC
    Ann Surg; 2012 Oct; 256(4):573-80. PubMed ID: 22964741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.